En savoir plus
Hematological cancers or blood cancers are a heterogeneous group of malignant neoplasms, including leukemia, lymphoma, and myeloma, primarily affect the blood and bone marrow. The "Hematological Cancer Pathophysiology: An Interdisciplinary Approach" is the tenth volume of the "Interdisciplinary Cancer Research" series, publishes a comprehensive volume on the pathophysiology of hematological cancers. This volume has an interdisciplinary approach in hematological cancers, including myeloproliferative neoplasms, T-cell lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, and intraocular lymphoma. Waldenstrom macroglobulinemia and IgG4-related diseases are also discussed in the last chapters. This interdisciplinary series is of special value to researchers working on hematology and oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to hematologists and oncologists who wish to extend their knowledge on hematological cancers.
Table des matières
Interdisciplinary Approach in Hematological Cancers.- Immunodeficiency, Leukemia, and Lymphoma.- Pathogenesis and Consequences of a Disruption to the Intestinal Barrier Functions in Patients with Hematologic Malignancies.- Autophagy as a Limiting Factor to the Effectiveness of Tyrosine Kinase Inhibitors in Blood Cancers.- Immunogenetic Factors in the Pathogenesis of Myeloproliferative Neoplasms.- Germline Predisposition in the Field of Myeloproliferative Neoplasms.- Enteropathy-Associated T-cell Lymphoma: Epidemiology, Natural History and Management in the Current Era.- Molecular Pathogenesis of Hodgkin's Lymphoma: Advances Through the Key Player LMP1 and 3D Nanotechnology.- Updates on Molecular Pathogenesis of Non-Hodgkin's Lymphoma.- Intraocular Lymphoma.- Bleeding in the Setting of Lymphoma, with a Focus on Waldenström Macroglobulinaemia.- The Role of EBV and Immune Deregulation in the Development of IgG4-related Diseases.
A propos de l'auteur
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,500 scientific papers in the international journals.
